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LETTER TO THE EDITOR
Seizures in nonketotic hyperglycaemia
Dear Sir,
The association between focal seizures and hyper-
glycaemia was first reported in 19651. The disorder is
characterized by hyperglycaemia, no ketoacidosis, full
consciousness (or minimal depression of sensorium)
and focal seizures. We report 21 patients, who pre-
sented with seizures and nonketotic hyperglycaemia
(NKH). This is a large case series. The aim of this re-
port is to study clinical and laboratory characteristics
of seizures in NKH.
A retrospective study was done in a teaching hospi-
tal. Inclusion criteria were (1) hyperglycaemia (plasma
glucose more than 11.11 mmol/l), (2) seizures, and (3)
seizure stopping after control of the hyperglycaemia.
Patients with seizures explained by causes other than
hyperglycaemia were excluded from the study. Of the
21 patients, 9 were men (43%) and 12 were women
(57%) who developed seizures and NKH (23 events).
One patient had three events. Six patients had a
previous history of diabetes mellitus (DM). Fifteen
patients had no previous history of DM. They pre-
sented with seizures and NKH, and were diagnosed
with DM in the index admission. Of the 21 patients,
3 were DM type 1 (14.3%) and 18 were DM type
2 (85.7%). The average duration of seizures before
admission was 5 days (range 1–14 days). The average
duration of seizures in each episode was 3 minutes
(range 1–5 minutes). Total of 22 events (95.65%)
were partial seizures, and 1 event was an unclassi-
fied tonic-clonic seizure. Among the 22 partial onset
seizures, 14 were epilepsia partialis continua, 6 be-
came secondarily generalized tonic-clonic seizures,
and 2 were complex partial seizures (CPS). In all 20
events of partial seizures without CPS, seizures started
in one extremity or the face: 14 started in an upper
extremity, 5 in the face, and 1 in a lower extremity.
Partial seizures started slightly more often on the left
side (12 cases) than the right side (8 cases). At the
time of the seizure, the average plasma glucose value
was 32.61 mmol/l (range 16.11–61.33 mmol/l). The
average calculated serum osmolarity was 302 mOsm/l
(range 288–323 mOsm/l). When the seizures stopped,
the average plasma glucose value was 11.3 mmol/l
(range 4.11–21.67 mmol/l).
Neurologic manifestations, particularly seizures,
may provide the first clinical clue to the presence of
NKH. Focal motor seizures are the most common
type2. However, seizures in NKH are still not fully
appreciated by physician and patient. Our patients
took an average of 5 days before they got the correct
diagnosis and treatment. Knowledge of this condition
may shorten the time to diagnosis and decrease the
discomfort of patients. Every patient who presents
with seizures especially focal seizures should have
an immediate determination of plasma glucose levels.
Seizures in NKH happen equally in both sexes. In 15
of the 21 patients (71.4%), seizures were the earliest
manifestation of DM and led to discovery of DM
in these patients. Most of patients had type 2 DM.
Although 3 of the 21 patients had type 1 DM, none
of them had ketoacidosis during the seizure. This
finding may be explained by the fact that ketosis has
an anticonvulsant action, due to intracellular acidosis
increasing glutamic acid and decarboxylase activity
leading to increased levels of GABA3. Epilepsia par-
tialis continua was the most common type (60.87%)
of seizure in our series, as previously reported2. Inter-
estingly, we found 2 (8.7%) of our patients presented
with CPS. Our finding confirmed previous reports of
CPS induced by hyperglycaemia4. The mechanism
of seizures in NKH is still debated. The possible
mechanisms are hyperglycaemia or hyperosmolarity,
a low level of gamma aminobutyric acid (GABA),
and focal ischaemia. Each mechanism, considered
alone, is unsatisfactory. Mean plasma glucose value
in our report was 32.61 (16.11–61.33 mmol/l), and
osmolarity ranged from normal to a moderate value
(288–323 mOsm/l). Almost all of our seizures in
NKH patients have plasma osmolarity less than the
classical diagnostic level (320 mOsm/l) of NKH. In
addition, mean plasma glucose ranged from nor-
mal to hyperglycaemia (4.11–21.67 mmol/l) when
seizures stopped. So, the explanation of hypergly-
caemia or hyperosmolarity alone is unsatisfactory.
In addition, the Krebs cycle in NKH is inhibited,
GABA metabolism is increased and the levels may
be decreased, thus lowering the threshold for seizure
activtiy3, 5.
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The clinical and laboratory characteristics features
of hyperglycaemic-induced seizures are: (1) mod-
erately severe hyperglycaemia (plasma glucose >
16.11 mmol/l); (2) moderate hyperosmolarity (plasma
osmolarity > 288 mOsm/l); (3) seizures, especially
focal seizures; (4) seizures stopping immediately after
normalizing plasma glucose and plasma osmolarity.
All of the patients had a normal CT-scan brain find-
ing and did not require antiepileptic drugs (AEDs).
Focal seizures in NKH are refractory to AEDs and
respond best to insulin and rehydration. In all the
patients seizures ceased on correction of the hyper-
glycaemia. This is important, because such seizures
are refractory to the usual AEDs.
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